Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer
Lactococcus lactis subsp. lactis transformed with Plasmid ss80 (encoding the production and secretion of TEM β-lactamase) was used for the delivery of β-lactamase through the C-33A (cervix cell) monolayer. The viability of the cell monolayers co-cultured with L. lactis was examined by the trypan blu...
Gespeichert in:
| Veröffentlicht in: | International journal of pharmaceutics 2006-04, Vol.313 (1), p.29-35 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 35 |
|---|---|
| container_issue | 1 |
| container_start_page | 29 |
| container_title | International journal of pharmaceutics |
| container_volume | 313 |
| creator | Kaushal, Gagan Trombetta, Louis Ochs, Raymond S. Shao, Jun |
| description | Lactococcus lactis subsp.
lactis transformed with Plasmid ss80 (encoding the production and secretion of TEM β-lactamase) was used for the delivery of β-lactamase through the C-33A (cervix cell) monolayer. The viability of the cell monolayers co-cultured with
L. lactis was examined by the trypan blue exclusion method. The integrity of the monolayers was monitored by measuring the transport of mannitol and propranolol as well as the transepithelial electrical resistance. The transport rate of β-lactamase through C-33A monolayer was increased by four- and nine-folds (
p
<
0.05) at the first hour by the transformed
L. lactis compared to the free solution with or without presence of the untransformed
L. lactis, respectively. This increase was gradually diminished after the 1st hour: it became 30 and 50% (
p
<
0.05) at 10
h. The presence of the untransformed
L. lactis with free solution delivery also increased the transport rate by 100% at 1
h (
p
<
0.05) and 15% at 10
h (
p
>
0.05). The increase in transport rate by the transformed
L. lactis is most probably due to the concentrate of β-lactamase on C-33A monolayer. When co-cultured with the
L. lactis, the C-33A cell viability and the monolayer TEER remained steady for 10
h. The presence of
L. lactis did not change the transport of propranolol and mannitol through the monolayers. In conclusion, the transformed
L. lactis significantly (
p
<
0.05) increased the transport of β-lactamase through the cervical monolayers, indicating probiotic bacteria delivery may be a promising approach for protein delivery through the vagina. |
| doi_str_mv | 10.1016/j.ijpharm.2006.01.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67805144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517306000585</els_id><sourcerecordid>19963514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-af7106b3d105df67b5a3a4ed8677d99a12d57fabe96bd70c033ef5f1fc6473c53</originalsourceid><addsrcrecordid>eNqFkcFu3CAQhlGVqNmmfYRWXNKbXVgM2KcoSpO20ka5JGeEYciyss0G7JX2tfIgfaawWkc5RhppBvEN_Pp_hL5TUlJCxa9N6TfbtY59uSRElITmYp_QgtaSFayS4gQtCJN1walkZ-hLShuSwSVln9EZFVVdk4Yv0PNv6PwO4h4Hhx9u7vD_l6LTZtS9ToDbPX6CAYox6iG5EHuweJVvgwnGTAkfSJ9wmtq0Ld9O4zqG6WmNDcSdN7rLQ9fhPgyh03uIX9Gp012Cb3M_R4-3Nw_Xf4vV_Z9_11erwlTLaiy0k5SIlllKuHVCtlwzXYGthZS2aTRdWi6dbqERrZXEEMbAcUedEZVkhrNz9PP47jaG5wnSqHqfDlL0AGFKSsiacFpVH4K0aQTLZAb5ETQxpBTBqW30vY57RYk6hKI2ag5FHUJRhOZiee_H_MHUZgfft-YUMnAxAzplw1x22_j0zkkhBBMkc5dHDrJvOw9RJeNhMGB9BDMqG_wHUl4BZZyvpw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19963514</pqid></control><display><type>article</type><title>Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kaushal, Gagan ; Trombetta, Louis ; Ochs, Raymond S. ; Shao, Jun</creator><creatorcontrib>Kaushal, Gagan ; Trombetta, Louis ; Ochs, Raymond S. ; Shao, Jun</creatorcontrib><description>Lactococcus lactis subsp.
lactis transformed with Plasmid ss80 (encoding the production and secretion of TEM β-lactamase) was used for the delivery of β-lactamase through the C-33A (cervix cell) monolayer. The viability of the cell monolayers co-cultured with
L. lactis was examined by the trypan blue exclusion method. The integrity of the monolayers was monitored by measuring the transport of mannitol and propranolol as well as the transepithelial electrical resistance. The transport rate of β-lactamase through C-33A monolayer was increased by four- and nine-folds (
p
<
0.05) at the first hour by the transformed
L. lactis compared to the free solution with or without presence of the untransformed
L. lactis, respectively. This increase was gradually diminished after the 1st hour: it became 30 and 50% (
p
<
0.05) at 10
h. The presence of the untransformed
L. lactis with free solution delivery also increased the transport rate by 100% at 1
h (
p
<
0.05) and 15% at 10
h (
p
>
0.05). The increase in transport rate by the transformed
L. lactis is most probably due to the concentrate of β-lactamase on C-33A monolayer. When co-cultured with the
L. lactis, the C-33A cell viability and the monolayer TEER remained steady for 10
h. The presence of
L. lactis did not change the transport of propranolol and mannitol through the monolayers. In conclusion, the transformed
L. lactis significantly (
p
<
0.05) increased the transport of β-lactamase through the cervical monolayers, indicating probiotic bacteria delivery may be a promising approach for protein delivery through the vagina.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2006.01.013</identifier><identifier>PMID: 16488095</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Bacterial Adhesion ; beta-Lactamases - genetics ; beta-Lactamases - metabolism ; Bioavailability ; Biological and medical sciences ; C-33A ; Cell Line, Tumor ; Cervix Uteri - cytology ; Cervix Uteri - metabolism ; Epithelial Cells - metabolism ; Female ; General pharmacology ; Humans ; Lactococcus lactis ; Lactococcus lactis - genetics ; Lactococcus lactis - metabolism ; Medical sciences ; Normal flora ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Protein delivery ; TEM β-lactamase ; Time Factors ; Transformation, Bacterial ; Vaginal delivery</subject><ispartof>International journal of pharmaceutics, 2006-04, Vol.313 (1), p.29-35</ispartof><rights>2006 Elsevier B.V.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-af7106b3d105df67b5a3a4ed8677d99a12d57fabe96bd70c033ef5f1fc6473c53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2006.01.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17666360$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16488095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaushal, Gagan</creatorcontrib><creatorcontrib>Trombetta, Louis</creatorcontrib><creatorcontrib>Ochs, Raymond S.</creatorcontrib><creatorcontrib>Shao, Jun</creatorcontrib><title>Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Lactococcus lactis subsp.
lactis transformed with Plasmid ss80 (encoding the production and secretion of TEM β-lactamase) was used for the delivery of β-lactamase through the C-33A (cervix cell) monolayer. The viability of the cell monolayers co-cultured with
L. lactis was examined by the trypan blue exclusion method. The integrity of the monolayers was monitored by measuring the transport of mannitol and propranolol as well as the transepithelial electrical resistance. The transport rate of β-lactamase through C-33A monolayer was increased by four- and nine-folds (
p
<
0.05) at the first hour by the transformed
L. lactis compared to the free solution with or without presence of the untransformed
L. lactis, respectively. This increase was gradually diminished after the 1st hour: it became 30 and 50% (
p
<
0.05) at 10
h. The presence of the untransformed
L. lactis with free solution delivery also increased the transport rate by 100% at 1
h (
p
<
0.05) and 15% at 10
h (
p
>
0.05). The increase in transport rate by the transformed
L. lactis is most probably due to the concentrate of β-lactamase on C-33A monolayer. When co-cultured with the
L. lactis, the C-33A cell viability and the monolayer TEER remained steady for 10
h. The presence of
L. lactis did not change the transport of propranolol and mannitol through the monolayers. In conclusion, the transformed
L. lactis significantly (
p
<
0.05) increased the transport of β-lactamase through the cervical monolayers, indicating probiotic bacteria delivery may be a promising approach for protein delivery through the vagina.</description><subject>Bacterial Adhesion</subject><subject>beta-Lactamases - genetics</subject><subject>beta-Lactamases - metabolism</subject><subject>Bioavailability</subject><subject>Biological and medical sciences</subject><subject>C-33A</subject><subject>Cell Line, Tumor</subject><subject>Cervix Uteri - cytology</subject><subject>Cervix Uteri - metabolism</subject><subject>Epithelial Cells - metabolism</subject><subject>Female</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lactococcus lactis</subject><subject>Lactococcus lactis - genetics</subject><subject>Lactococcus lactis - metabolism</subject><subject>Medical sciences</subject><subject>Normal flora</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein delivery</subject><subject>TEM β-lactamase</subject><subject>Time Factors</subject><subject>Transformation, Bacterial</subject><subject>Vaginal delivery</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu3CAQhlGVqNmmfYRWXNKbXVgM2KcoSpO20ka5JGeEYciyss0G7JX2tfIgfaawWkc5RhppBvEN_Pp_hL5TUlJCxa9N6TfbtY59uSRElITmYp_QgtaSFayS4gQtCJN1walkZ-hLShuSwSVln9EZFVVdk4Yv0PNv6PwO4h4Hhx9u7vD_l6LTZtS9ToDbPX6CAYox6iG5EHuweJVvgwnGTAkfSJ9wmtq0Ld9O4zqG6WmNDcSdN7rLQ9fhPgyh03uIX9Gp012Cb3M_R4-3Nw_Xf4vV_Z9_11erwlTLaiy0k5SIlllKuHVCtlwzXYGthZS2aTRdWi6dbqERrZXEEMbAcUedEZVkhrNz9PP47jaG5wnSqHqfDlL0AGFKSsiacFpVH4K0aQTLZAb5ETQxpBTBqW30vY57RYk6hKI2ag5FHUJRhOZiee_H_MHUZgfft-YUMnAxAzplw1x22_j0zkkhBBMkc5dHDrJvOw9RJeNhMGB9BDMqG_wHUl4BZZyvpw</recordid><startdate>20060426</startdate><enddate>20060426</enddate><creator>Kaushal, Gagan</creator><creator>Trombetta, Louis</creator><creator>Ochs, Raymond S.</creator><creator>Shao, Jun</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20060426</creationdate><title>Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer</title><author>Kaushal, Gagan ; Trombetta, Louis ; Ochs, Raymond S. ; Shao, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-af7106b3d105df67b5a3a4ed8677d99a12d57fabe96bd70c033ef5f1fc6473c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Bacterial Adhesion</topic><topic>beta-Lactamases - genetics</topic><topic>beta-Lactamases - metabolism</topic><topic>Bioavailability</topic><topic>Biological and medical sciences</topic><topic>C-33A</topic><topic>Cell Line, Tumor</topic><topic>Cervix Uteri - cytology</topic><topic>Cervix Uteri - metabolism</topic><topic>Epithelial Cells - metabolism</topic><topic>Female</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lactococcus lactis</topic><topic>Lactococcus lactis - genetics</topic><topic>Lactococcus lactis - metabolism</topic><topic>Medical sciences</topic><topic>Normal flora</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein delivery</topic><topic>TEM β-lactamase</topic><topic>Time Factors</topic><topic>Transformation, Bacterial</topic><topic>Vaginal delivery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaushal, Gagan</creatorcontrib><creatorcontrib>Trombetta, Louis</creatorcontrib><creatorcontrib>Ochs, Raymond S.</creatorcontrib><creatorcontrib>Shao, Jun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaushal, Gagan</au><au>Trombetta, Louis</au><au>Ochs, Raymond S.</au><au>Shao, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2006-04-26</date><risdate>2006</risdate><volume>313</volume><issue>1</issue><spage>29</spage><epage>35</epage><pages>29-35</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Lactococcus lactis subsp.
lactis transformed with Plasmid ss80 (encoding the production and secretion of TEM β-lactamase) was used for the delivery of β-lactamase through the C-33A (cervix cell) monolayer. The viability of the cell monolayers co-cultured with
L. lactis was examined by the trypan blue exclusion method. The integrity of the monolayers was monitored by measuring the transport of mannitol and propranolol as well as the transepithelial electrical resistance. The transport rate of β-lactamase through C-33A monolayer was increased by four- and nine-folds (
p
<
0.05) at the first hour by the transformed
L. lactis compared to the free solution with or without presence of the untransformed
L. lactis, respectively. This increase was gradually diminished after the 1st hour: it became 30 and 50% (
p
<
0.05) at 10
h. The presence of the untransformed
L. lactis with free solution delivery also increased the transport rate by 100% at 1
h (
p
<
0.05) and 15% at 10
h (
p
>
0.05). The increase in transport rate by the transformed
L. lactis is most probably due to the concentrate of β-lactamase on C-33A monolayer. When co-cultured with the
L. lactis, the C-33A cell viability and the monolayer TEER remained steady for 10
h. The presence of
L. lactis did not change the transport of propranolol and mannitol through the monolayers. In conclusion, the transformed
L. lactis significantly (
p
<
0.05) increased the transport of β-lactamase through the cervical monolayers, indicating probiotic bacteria delivery may be a promising approach for protein delivery through the vagina.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>16488095</pmid><doi>10.1016/j.ijpharm.2006.01.013</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-5173 |
| ispartof | International journal of pharmaceutics, 2006-04, Vol.313 (1), p.29-35 |
| issn | 0378-5173 1873-3476 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67805144 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Bacterial Adhesion beta-Lactamases - genetics beta-Lactamases - metabolism Bioavailability Biological and medical sciences C-33A Cell Line, Tumor Cervix Uteri - cytology Cervix Uteri - metabolism Epithelial Cells - metabolism Female General pharmacology Humans Lactococcus lactis Lactococcus lactis - genetics Lactococcus lactis - metabolism Medical sciences Normal flora Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Protein delivery TEM β-lactamase Time Factors Transformation, Bacterial Vaginal delivery |
| title | Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A43%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Delivery%20of%20TEM%20%CE%B2-lactamase%20by%20gene-transformed%20Lactococcus%20lactis%20subsp.%20lactis%20through%20cervical%20cell%20monolayer&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Kaushal,%20Gagan&rft.date=2006-04-26&rft.volume=313&rft.issue=1&rft.spage=29&rft.epage=35&rft.pages=29-35&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2006.01.013&rft_dat=%3Cproquest_cross%3E19963514%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19963514&rft_id=info:pmid/16488095&rft_els_id=S0378517306000585&rfr_iscdi=true |